MedTech Business - September 30, 2014
Elekta gets Chinese clearance for radiation therapy system
The China Food and Drug Administration (CFDA) has cleared Elekta’s Versa HD radiation therapy system for sale and marketing in the country. Versa HD is equipped with the Agility multileaf collimator for high-speed, high-precision beam shaping to support accurate tumor targeting and improved healthy tissue preservation. Elekta’s Anming Gong, Managing Director for China, says: “As cancer […]
Uncategorized - September 29, 2014
KI in new cancer consortium
Karolinska Institute develops cancer diagnostics and treatments in a new European consortium. A new European consortium is now being built – Cancer Core Europe – in which six of Europe’s most prominent cancer research centres take part. Karolinska Institutet is one of them. “KI wants to be part of creating new and improved treatment methods […]
Financing - September 29, 2014
Nanovi secures EUR 2.7 million to market BioXmark
Nanovi, specialized in the development of advanced biomaterials for use in the radiotherapy of cancer, has secured EUR 2.7M from current investors to bring BioXmark technology to the market. BioXmark is a novel injectable liquid tissue marker which improves the accuracy and quality of radiation therapy and will be available for commercial use in Europe during the […]
New Market - September 26, 2014
Enzymatica gets first order for veterinary products
The company’s partner Adartis Animal Health has placed a first order for the veterinary products that Enzymatica launched in the United States and Canada in July 2014. The order includes Kalvatin products to a value of about SEK 3 million. According to Enzymatica the order is expected to cover market needs for the next six to […]
Pharma Business - September 26, 2014
Novo Nordisk establishes new obesity research unit in Seattle
The obesity research unit will be co-located with the Novo Nordisk type 1 diabetes research unit at the company’s research centre in Seattle, which opened in 2009. The new unit is a result of Novo Nordisk’s increasing focus on treatment of obesity with the aim to identify novel approaches and targets for obesity treatments while increasing […]
Collaboration - September 26, 2014
Probi expands collaboration
Probi and Pharmavite expand collaboration in the US and international markets. The two companies have signed a new long-term agreement for distribution and marketing of Probi’s probiotic products. Pharmavite launched Probi Digestis capsules based on Probi’s flagship strain LP299V in the US market under the Nature Made brand in 2012 and have accounted for a significant portion of Probi’s […]
